FDA Approves New Absorbable Heart Stent Tested at Scripps

Scripps cardiologist Paul Teirstein, MD, weighs in on the promise of the new technology

Scripps cardiologist Paul Teirstein, MD, weighs in on the promise of the new technology

Scripps Clinic cardiologist Paul Teirstein, MD, weighed in on a new absorbable stent recently cleared for commercial use by the Food and Drug Administration in an article published by the San Diego Union-Tribune.


Dr. Teirstein, who is medical director of the Prebys Cardiovascular Institute, oversaw the testing of the Absorb bioresorbable vascular scaffold system among Scripps cardiology patients.


Read the Union-Tribune article: FDA Approves Potentially ‘Revolutionary’ Heart Stent.

Media Contact

Keith Darce
858-678-7121
darce.keith@scrippshealth.org
Follow me: @KeithDarce